End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.83 CNY | +1.86% | +6.09% | -20.37% |
Feb. 05 | Jinhe Biotechnology CO., LTD. announces an Equity Buyback for CNY 100 million worth of its shares. | CI |
Feb. 05 | Jinhe Biotechnology CO., LTD. authorizes a Buyback Plan. | CI |
Sales 2021 | 2.08B 289M | Sales 2022 | 2.12B 295M | Capitalization | 3.87B 538M |
---|---|---|---|---|---|
Net income 2021 | 94M 13.06M | Net income 2022 | 75M 10.42M | EV / Sales 2021 | 2.54 x |
Net Debt 2021 | 490M 68.13M | Net Debt 2022 | 1.11B 154M | EV / Sales 2022 | 2.35 x |
P/E ratio 2021 |
43.8
x | P/E ratio 2022 |
53.1
x | Employees | 2,292 |
Yield 2021 * |
-
| Yield 2022 |
1.95% | Free-Float | 53.74% |
1 day | +1.86% | ||
1 week | +6.09% | ||
Current month | +4.93% | ||
1 month | +17.13% | ||
3 months | -21.68% | ||
6 months | -21.52% | ||
Current year | -20.37% |
Managers | Title | Age | Since |
---|---|---|---|
Chang Xian Xie
CEO | Chief Executive Officer | 62 | 98-12-31 |
You Shan Niu
DFI | Director of Finance/CFO | 53 | 07-12-31 |
Zhi Jun Wang
BRD | Director/Board Member | 50 | 91-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wen Bing Lu
BRD | Director/Board Member | 57 | 20-06-01 |
Xing Ming Zhang
BRD | Director/Board Member | 60 | - |
Zhi Jun Wang
BRD | Director/Board Member | 50 | 91-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 3.83 | +1.86% | 8,326,999 |
24-03-15 | 3.76 | +1.35% | 6,629,243 |
24-03-14 | 3.71 | -0.80% | 6,060,400 |
24-03-13 | 3.74 | 0.00% | 9,352,300 |
24-03-12 | 3.74 | +3.60% | 10,834,200 |
End-of-day quote Shenzhen S.E., March 17, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.37% | 401M | |
-13.52% | 78.15B | |
+5.91% | 7.78B | |
+7.88% | 3.22B | |
-7.79% | 3.1B | |
-1.55% | 1.37B | |
-20.15% | 1.34B | |
+2.54% | 1.36B | |
-18.57% | 1.32B | |
-18.89% | 1.07B |